Loading…
Loading…
| # | Company | Status |
|---|---|---|
| 1 | Admitted-Finance | Admitted-Finance |
| 2 | Rejected-Technical | Rejected-Technical Technically not accepted |
| 3 | Rejected-Technical | Rejected-Technical Technically not accepted |
Tender Value
Refer Docs
Closing Date
23 Nov 2021, 2:00 pmClosed
CFAO
Institute of Nano Science and Technology, Sector 81, Mohali
Supply of Antibodies as per NIT document.
2021_INST_655075_1
INST/12(258)/2021-Pur
Open Tender
Miscellaneous Goods
Supply
30 days
INST Mohali
Please refer Tender documents.
2 documents required · 2 mandatory
₹0
Exempted
20 Dec 2021
29 Oct 2021
24 Nov 2021
29 Oct 2021
23 Nov 2021
29 Oct 2021
Anti-c-Myb Antibody (D-7)
Anti-3pK Antibody (B-2)
Anti-Oct-3/4 Antibody (C-10)
Anti-caspase-3 Antibody (31A1067)
Anti-Bmi-1 Antibody (F-9)
Anti-ENX-1 Antibody (C-1)
Anti-α-synuclein Antibody (211)
Anti-B23/Nucleophosmin Antibody (E-3)
Anti-RING1B Antibody (N-32)
B23 CRISPR/Cas9 KO Plasmid (h)
Anti-SOCS-3 Antibody (6A463)
Anti-Calpain Antibody (B-8)
Anti-Sox-2 Antibody (A-5)
mouse anti-rabbit IgG-HRP
goat anti-mouse IgG-HRP
mouse anti-goat IgG-HRP
Control siRNA (FITC Conjugate)-A
siRNA Transfection Medium
siRNA Transfection Reagent
Bcl-2 siRNA (h)
Oct-3/4 siRNA (h)
Sox-2 siRNA (h)
JMJD3 siRNA (h)
Any other charges, if any (A)
Any other charges, if any (B)
Any other charges, if any (C)
Any other charges, if any (D)
stage.html
html • 0.03 MB
tech_bid_open.pdf
tech_eval.pdf
fin_bid_open.pdf
boq_comp_chart.xlsx
xlsx
Tap a document below to read it instantly. You can also download everything as a ZIP if you prefer.
details.html
html • 0.03 MB
Download all tender documents and submit your bid
Disclaimer: TenderKart has made every reasonable effort to ensure that the information on this page is accurate and authentic, however it cannot be held liable for any third-party claims or losses or any damages. TenderKart makes no warranty, expressed or implied, as to the results obtained from the use of this information. If you notice any error or omission, please let us know at .